NICE's cost effectiveness threshold
BMJ
.
2007 Aug 25;335(7616):358-9.
doi: 10.1136/bmj.39308.560069.BE.
Authors
John Appleby
,
Nancy Devlin
,
David Parkin
PMID:
17717337
PMCID:
PMC1952475
DOI:
10.1136/bmj.39308.560069.BE
Abstract
How high should it be?
Publication types
Editorial
MeSH terms
Alzheimer Disease / drug therapy*
Alzheimer Disease / economics
Cost-Benefit Analysis
Government Agencies
Health Policy
Humans
Quality-Adjusted Life Years
United Kingdom